Decellularized tissue-engineered blood vessel as an arterial conduit
暂无分享,去创建一个
Laura E Niklason | Roberto J Manson | L. Niklason | A. Dardik | J. Lawson | Alan Dardik | Jeffrey H Lawson | Clay Quint | Yuka Kondo | Y. Kondo | Clay Quint | R. Manson
[1] S. Epstein,et al. Akt Controls Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Delaying G1/S Exit , 2003, Circulation research.
[2] F A Auger,et al. A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Nick D. Tsihlis,et al. The role of nitric oxide in the pathophysiology of intimal hyperplasia. , 2007, Journal of vascular surgery.
[4] Seung‐Woo Cho,et al. Small-Diameter Blood Vessels Engineered With Bone Marrow–Derived Cells , 2005, Annals of surgery.
[5] M. Gimbrone,et al. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] Vikas Prabhakar,et al. Decellularized native and engineered arterial scaffolds for transplantation. , 2003, Cell transplantation.
[7] F. Miyawaki,et al. Experience of vein grafting in Göttingen minipigs. , 2001, Experimental animals.
[8] J. Pober,et al. Interferon-&ggr; Induces Human Vascular Smooth Muscle Cell Proliferation and Intimal Expansion by Phosphatidylinositol 3-Kinase–Dependent Mammalian Target of Rapamycin Raptor Complex 1 Activation , 2007, Circulation research.
[9] J. Pober,et al. Porcine Endothelial Cells, Unlike Human Endothelial Cells, Can Be Killed by Human CTL Via Fas Ligand and Cannot Be Protected by Bcl-21 , 2002, The Journal of Immunology.
[10] G. Truskey,et al. Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. , 2009, Tissue engineering. Part A.
[11] Patrick W Serruys,et al. Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting Stents , 2005, Circulation.
[12] M. Yoder,et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.
[13] R Langer,et al. Morphologic and mechanical characteristics of engineered bovine arteries. , 2001, Journal of vascular surgery.
[14] A. Nicolaides,et al. Pre-bypass quality assessment of the long saphenous vein wall with ultrasound and histology. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[15] C. Schmidt,et al. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. , 2000, Biomaterials.
[16] K. Ley,et al. Journal of Thrombosis and Haemostasis, 1: 1699±1709 REVIEW ARTICLE The role of in¯ammation in vascular injury and repair , 2022 .
[17] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[18] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Libby,et al. Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.
[20] R. Hobson,et al. Differential patency and limb salvage for polytetrafluoroethylene and autogenous saphenous vein in severe lower extremity ischemia. , 1982, Surgery.
[21] L. Niklason,et al. Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs) , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Simon C Watkins,et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. , 2001, Journal of vascular surgery.
[23] L. Niklason,et al. Novel utilization of serum in tissue decellularization. , 2010, Tissue engineering. Part C, Methods.
[24] Marcin Maruszewski,et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study , 2009, The Lancet.
[25] R Langer,et al. Functional arteries grown in vitro. , 1999, Science.
[26] G. Truskey,et al. Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress. , 2009, Tissue engineering. Part A.
[27] Anthony Atala,et al. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. , 2006, Tissue engineering.
[28] C. D. Owens,et al. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. , 2010, Journal of vascular surgery.
[29] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[30] Anthony Atala,et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.
[31] Christopher Breuer,et al. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. , 2005, Journal of vascular surgery.
[32] E Bell,et al. A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.
[33] M. Mann,et al. Cell Cycle Protein Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Is Regulated Through Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[34] Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. , 2008, The American journal of pathology.
[35] D. Fingar,et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. , 2004, American journal of physiology. Cell physiology.
[36] Laura E Niklason,et al. Readily Available Tissue-Engineered Vascular Grafts , 2011, Science Translational Medicine.
[37] M. Yoder,et al. Isolation and characterization of endothelial progenitor cells from human blood. , 2008, Current protocols in stem cell biology.
[38] F. Veith,et al. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. , 1979, Surgery.
[39] F. Timmermans,et al. Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.